NASA’s Office of the Chief Health and Medical Officer formed a working group in August 2026 to review the most recent data related to extravehicular activity (EVA) prebreathe testing and decompression sickness (DCS) events, venous thromboembolism (VTE) in-flight occurrences, and patent foramen ovale (PFO) implication as they relate to NASA’s Artemis (lunar and beyond) missions. The recommendations from this working group are built upon and integrate the outcomes of previous working groups hosted by OCHMO.
NASA Reviews Health Risks for Astronauts in Artemis Missions
NASA's Office of the Chief Health and Medical Officer has formed a working group to analyze risks associated with spaceflight, specifically focusing on decompression sickness and venous thromboembolism during Artemis missions. This review builds on previous findings and is crucial for ensuring astronaut health in future lunar missions. Although not directly related to Iran, advancements in space technology could influence Iran's own space ambitions.
👥 Key Players
📰 What Happened
NASA's Office of the Chief Health and Medical Officer has established a working group to assess health risks related to space missions, focusing on conditions like decompression sickness and venous thromboembolism. This review is essential for ensuring astronaut safety during the upcoming Artemis missions.
- The working group was formed in August 2026.
- The review builds on previous findings related to astronaut health.
💡 Why It Matters
📚 Background
NASA's Artemis program aims to return humans to the Moon and eventually send astronauts to Mars, necessitating thorough health assessments for astronaut safety.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%